Physician

Prasad V Kanneganti, MD

According to 2025 Medicare claims, Prasad Kanneganti, MD (NPI: 1649260423) practices neurology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is ST VINCENT HOSPITAL-HOSPITAL SISTERS-THIRD ORDER OF ST FRANCIS (NPI: 1285613638; TIN: 39-0817529) and primary practice location at 54301-2253. Kanneganti is affiliated with the HSHS ACO, L.L.C. (ACO ID: A2783), OSF Healthcare System (ACO ID: A3289), and THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Kanneganti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 512 traditional Medicare patients, billed 8,962 HCPCS/CPT codes, and received $139,580 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,294 prescription claims across 560 beneficiaries totaling $3,815,413 in drug costs, led by Nexviazyme (Avalglucosidase Alfa-Ngpt). 2022 DME data shows 16 claims. Open Payments data shows 42 records totaling $4,540. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,626,304 to $3,815,413. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,803 to $17,123.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$72K$143K2015 Medicare payment: $115,628 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $124,665 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $143,057 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $139,026 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $129,335 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $111,395 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $132,527 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $127,221 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $106,774 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $139,580 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154726,464$115,628
20165108,760$124,665
20175437,643$143,057
20185438,888$139,026
20195346,289$129,335
20205423,233$111,395
20215277,233$132,527
20224947,468$127,221
20234536,269$106,774
20245128,962$139,580

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.8M2015 Drug cost: $1,626,304 (USD; Tot_Drug_Cst)2016 Drug cost: $1,797,763 (USD; Tot_Drug_Cst)2017 Drug cost: $1,907,307 (USD; Tot_Drug_Cst)2018 Drug cost: $2,543,346 (USD; Tot_Drug_Cst)2019 Drug cost: $2,492,732 (USD; Tot_Drug_Cst)2020 Drug cost: $2,441,566 (USD; Tot_Drug_Cst)2021 Drug cost: $2,823,245 (USD; Tot_Drug_Cst)2022 Drug cost: $2,908,406 (USD; Tot_Drug_Cst)2023 Drug cost: $3,775,083 (USD; Tot_Drug_Cst)2024 Drug cost: $3,815,413 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155064,569$1,626,304
20165584,697$1,797,763
20175864,666$1,907,307
20186054,714$2,543,346
20195724,427$2,492,732
20206084,697$2,441,566
20215664,858$2,823,245
20225934,584$2,908,406
20235354,227$3,775,083
20245604,294$3,815,413

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$38K$75K2016 Medicare payment: $1,690 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $61,646 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $61,195 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $56,784 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $62,773 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $66,382 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $75,198 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R12$1,690
2017N/R34$61,646
2018N/R24$61,195
2019N/R12$56,784
2020N/R13$62,773
2021N/R14$66,382
2022N/R16$75,198
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes224237$132
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5965$95
95816Measurement of brain wave activity (eeg), awake and drowsy6464$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more129139$57
36415Insertion of needle into vein for collection of blood sample6072$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NexviazymeAvalglucosidase Alfa-Ngpt13364$1,328,620
EvrysdiRisdiplam461,104$1,228,713
Kesimpta PenOfatumumab16476$131,967
EpidiolexCannabidiol (Cbd)16466$85,409
Aimovig AutoinjectorErenumab-Aooe632,107$53,256

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$4,540ARGENX US, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Prasad V. Kanneganti, MD?

Tedicare shows public-source Medicare data for Prasad V. Kanneganti, MD (NPI 1649260423), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Prasad V. Kanneganti, MD have ACO affiliation data?

Prasad V. Kanneganti, MD is shown with ACO affiliation data for HSHS ACO, L.L.C. (MSSP, ACO ID A2783), OSF Healthcare System (MSSP, ACO ID A3289), and THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Prasad V. Kanneganti, MD?

Prasad V. Kanneganti, MD is linked to ST VINCENT HOSPITAL-HOSPITAL SISTERS-THIRD ORDER OF ST FRANCIS (billing NPI 1285613638) in the available physician profile data.

Does Prasad V. Kanneganti, MD have Open Payments data?

Prasad V. Kanneganti, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.